Eotaxin-3 in Churg-Strauss syndrome: a clinical and immunogenetic study
Authors:
- J. ZwerinaJZJ. Zwerina
- C. BachCBC. Bach
- D. MartoranaDMD. Martorana
- M. JatzwaukMJM. Jatzwauk
- G. HegasyGHG. Hegasy
- F. MoosigFMF. Moosig
- J. BremerJBJ. Bremer
- S. WieczorekSWS. Wieczorek
- A. MoschenAMA. Moschen
- H. TilgHTH. Tilg
- T. NeumannTNT. Neumann
- B. M. SpriewaldBSB. M. Spriewald
- 25 January 2011
- journal article
- Published by Oxford University Press (OUP) in Rheumatology
- Vol. 50 (10) , 1823-1827
Abstract
To determine the potential of eotaxin-3 as a diagnostic marker for active disease and genetic susceptibility factor for Churg-Strauss syndrome (CSS). A total of 37 patients with active, relapsed or inactive CSS, 123 healthy controls and 138 disease controls were studied. Clinical data were collected and serum levels of eotaxin-3 were determined. Ex vivo stability of eotaxin-3 in serum samples was tested. Furthermore, the association of single nucleotide polymorphisms (SNPs) in the eotaxin-3 gene with CSS was determined in 161 CSS patients and 124 healthy controls. Serum eotaxin-3 was highly elevated in active CSS patients. Neither eosinophilic diseases nor other small-vessel vasculitides were associated with high serum eotaxin-3 levels. Receiver operating characteristic curve analysis determined a sensitivity and specificity of 87.5 and 98.6% at a cut-off level of 80 pg/ml. None of the tested SNPs within the eotaxin-3 gene influenced the susceptibility to develop CSS. Serum eotaxin-3 is a sensitive and specific marker for the diagnosis of active CSS suitable for routine clinical practice. Previously described SNPs in the eotaxin-3 gene do not predict the risk of developing CSS.Keywords
This publication has 14 references indexed in Scilit:
- Functionally relevant variations of the interleukin‐10 gene associated with antineutrophil cytoplasmic antibody–negative Churg‐Strauss syndrome, but not with Wegener's granulomatosisArthritis & Rheumatism, 2008
- Eotaxin-3 is involved in Churg-Strauss syndrome - a serum marker closely correlating with disease activityRheumatology, 2008
- Associations of Churg‐Strauss syndrome with the HLA–DRB1 locus, and relationship to the genetics of antineutrophil cytoplasmic antibody–associated vasculitides: Comment on the article by Vaglio et alArthritis & Rheumatism, 2007
- HLA–DRB4 as a genetic risk factor for Churg‐Strauss syndromeArthritis & Rheumatism, 2007
- Eotaxin-3 and a uniquely conserved gene-expression profile in eosinophilic esophagitisJournal of Clinical Investigation, 2006
- Antineutrophil Cytoplasmic Antibodies and the Churg–Strauss SyndromeAnnals of Internal Medicine, 2005
- Prevalence and clinical significance of antineutrophil cytoplasmic antibodies in Churg‐Strauss syndromeArthritis & Rheumatism, 2005
- Eotaxin-3 gene polymorphisms are associated with rheumatoid arthritis in a Korean populationHuman Immunology, 2005
- Analysis of the polymorphisms in eotaxin gene family and their association with asthma, IgE, and eosinophilBiochemical and Biophysical Research Communications, 2004
- THE HYPEREOSINOPHILIC SYNDROMEMedicine, 1975